Over the next decade, U.S. banks, which are investing $150 billion in technology annually, will use automation to eliminate 200,000 jobs, thus facilitating “the greatest transfer from labor to capital” in the industry’s history. The call is coming from inside the house this time, too—both the projection and the quote come from a recent Wells Fargo report, whose lead author, Mike Mayo, told the Financial Times that he expects the industry to shed 10 percent of all of its jobs.
As reported by the U.S. Air Force Research Laboratory, military scientists have developed a “Terminator-like” liquid metal that can autonomously change the structure, just like in a Hollywood movie.
The scientists developed liquid metal systems for stretchable electronics – that can be bent, folded, crumpled and stretched – are major research areas towards next-generation military devices.
Conductive materials change their properties as they are strained or stretched. Typically, electrical conductivity decreases and resistance increases with stretching.
Trade wars and a global economic slowdown are creating more opportunities for companies looking for better, cheaper automated options.
A first: paralyzed man uses brain signals to control a robot exoskeleton.
Doctors who conducted the trial said though the device was years away from being publicly available, it had the potential to improve patients’ quality of life and autonomy.
The patient, identified only as Thibault, 28, from Lyon, said the technology had given him a new lease of life. Four years ago his life was permanently changed when he fell 40ft (12 metres) from a balcony, severing his spinal cord and leaving him paralysed from the shoulders down.
“When you are in my position, when you can’t do anything with your body … I wanted to do something with my brain,” Thibault said.
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge.
BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have the potential to promote healthy lifespan (healthspan) by slowing down aging and the ill health that it brings.
As the vice president of in-vivo biology at BioAge, Dr. Rebo leads the company’s internal in-vivo platform to find and assess the viability of new druggable targets for aging diseases and biomedical regeneration. With considerable business as well as academic experience in the aging field under his belt, Justin joined the BioAge team in 2018.
Stuart Russell’s latest book examines how artificial intelligence could spin out of control. David Leslie critiques it.
DARPA expects to have a new commercial partner lined up for the Robotic Servicing of Geosynchronous Satellites spacecraft by the end of the year.
If you thought Cambridge Analytica had scary tech, wait until you see this. A new form of AI modelling promises accurate simulation of the behaviour of entire cities, countries and one day perhaps, the world.
